Invasive Measurement of Axial Plaque Stress, the Pilot Study (REASSURE)

March 9, 2015 updated by: Bon-Kwon Koo, Seoul National University Hospital

Relevance of Invasively Measured Axial Plaque Stress and Wall Shear Stress Using Invasive Coronary Imaging and Hemodynamic Data

In this study, the investigators sought to evaluate the feasibility of estimating external hemodynamic stress acting plaque with the use of invasively measured hemodynamic data from pressure wire pullback tracing.

In addition, the investigators will also evaluate detailed plaque geometry and vulnerability using optical coherence tomography along with the hemodynamic stress.

Study Overview

Status

Unknown

Detailed Description

It has been well known that mechanism of acute coronary syndrome is plaque rupture and occlusion of coronary artery by this plaque rupture. Although current risk assessment for plaque rupture have mainly focused on evaluation of plaque vulnerability. However, according to the general mechanism of material failure, plaque rupture occurs whenever the external hemodynamic stress exceeds the durability of the plaque.

Recently, we evaluated the axial plaque stress, which is axial component of total traction acting on the plaque, and showed that the axial plaque stress possess significantly higher magnitude than previously known wall shear stress.

However, the axial plaque stress in our previous research was measured with computational flow dynamics analysis using coronary artery model from coronary CT angiography.

In this study, we sought to evaluate the feasibility of estimating external hemodynamic stress acting plaque with the use of invasively measured hemodynamic data from pressure wire pullback tracing.

In addition, we will also evaluate detailed plaque geometry and vulnerability using optical coherence tomography along with the hemodynamic stress.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Daegu, Korea, Republic of
        • Keimyung University Dongsan Medical Center
      • Goyang, Korea, Republic of
        • Inje University Ilsan Paik Hospital
      • Seoul, Korea, Republic of
        • Seoul National University Hospital
      • Ulsan, Korea, Republic of
        • Ulsan University Hospital, University of Ulsan College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with angina pectoris

Description

Inclusion Criteria:

  • 1. Patients with angina pectoris who are scheduled to do invasive coronary angiography.
  • 2. Patients who have moderate (40-70%) stenosis at proximal or mid-portion of major coronary arteries.
  • 3. Pressure wire pullback tracing and Optical Coherence Tomography ware successfully performed

Exclusion Criteria:

  • 1. Stenosis at distal coronary or small vessel.
  • 2. Patients who don't have moderate (40-70%) stenosis at proximal or mid-portion of major coronary arteries. Confirmed by invasive coronary angiography.
  • 3. Inadequate quality of Optical Coherence Tomography
  • 4. No data of Fractional Flow Reserve or Pressure wire pullback tracing or inadequate data of Fractional Flow Reserve or Pressure wire pullback tracing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
OCT and Pressure wire pullback tracing
This study is pilot study evaluating the feasibility of invasive measurement and estimation of hemodynamic stress acting on plaque as well as co-registration of hemodynamic data with plaque geometric data, which is obtained by optical coherence tomography
Optical coherence tomography to evaluate plaque morphology and vulnerable features (ex> cap thickness, spotty calcification)
Other Names:
  • Optical coherence tomography
Resting and hyperemic pressure pullback tracing will be done with motorized pullback system.
Other Names:
  • Fractional flow reserve measurement with pressure pullback tracing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Axial plaque stress (Axial component of total traction acting on the plaque)
Time Frame: up to 1 week
up to 1 week
Cap thickness (measured from optical coherent tomography)
Time Frame: up to 1 week
Cap thickness measured from optical coherent tomography
up to 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wall shear stress (Friction vector on the surface of the plaque)
Time Frame: up to 1 week
Friction vector on the surface of the plaque
up to 1 week
Proportion of thin cap fibrous atheroma
Time Frame: up to 1 week
Plaques with cap thickness < 60um
up to 1 week
Cardiac death and all-cause mortality
Time Frame: 1 year
Between High-hemodynamic force plaque and Low-hemodynamic force plaque
1 year
Non-fatal target vessel myocardial infarction
Time Frame: 1 year
Between High-hemodynamic force plaque and Low-hemodynamic force plaque
1 year
Target vessel restenosis
Time Frame: 1 year
Between High-hemodynamic force plaque and Low-hemodynamic force plaque
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Anticipated)

March 1, 2017

Study Completion (Anticipated)

March 1, 2018

Study Registration Dates

First Submitted

March 4, 2015

First Submitted That Met QC Criteria

March 9, 2015

First Posted (Estimate)

March 17, 2015

Study Record Updates

Last Update Posted (Estimate)

March 17, 2015

Last Update Submitted That Met QC Criteria

March 9, 2015

Last Verified

March 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe